Exotic Animal Formulary5

89 Maguire R., Gallinato M.J. Novel treatment of Encephalitozoon cuniculi-induced
glaucoma in a rabbit. Proc Assoc Exot Mam Vet Conf. 2011;125.
90 Mans C. Personal communication. 2016.
91 Marangos M.N., Zhu Z., Nicolau D.P., et al. Disposition of ofloxacin in female
New Zealand white rabbits. J Vet Pharmacol Ther. 1997;20:17–20.
92 Marín P., Álamo L.F., Escudero E., et al. Pharmacokinetics of marbofloxacin in
rabbit after intravenous, intramuscular, and subcutaneous administration. Res
Vet Sci. 2013;94:698–700.
93 Mazaheri-Khameneh R., Sarrafzadeh-Rezaei F., Asri-Rezaei S., et al. Comparison
of time to loss of consciousness and maintenance of anesthesia following
intraosseous and intravenous administration of propofol in rabbits. J Am Vet Med
Assoc. 2012;241:73–80.
94 McElroy D.E., Ravis W.R., Clark C.H. Pharmacokinetics of oxytetracycline
hydrochloride in rabbits. Am J Vet Res. 1987;48:1261–1263.
95 McGee D.H., Holt W.F., Kastner P.R., et al. Safety of moxifloxacin as shown in
animal and in vitro studies. Surv Ophthalmol. 2005;50:S46–S54.
96 McTier T.L., Hair J.A., Walstrom D.J., et al. Efficacy and safety of topical
administration of selamectin for treatment of ear mite infestation in rabbits. J Am
Vet Med Assoc. 2003;223:322–324.
97 Mercier P, Morel-Saives A, Verdelhan S, et al. Tolerance of decoquinate in the
rabbit. Proc 8th World Rabbit Congr 2004; 597-600.
98 Miller J.L., Schell W.A., Wills E.A., et al. In vitro and in vivo efficacies of the new
triazole albaconazole against Cryptococcus neoformans. Antimicrob Agents
Chemother. 2004;48:384–387.
99 Nelson C.L., McLaren S.G., Skinner R.A., et al. The treatment of experimental
osteomyelitis by surgical debridement and the implantation of calcium sulfate
tobramycin pellets. J Orthop Res. 2002;20:643–647.
100 Nicolau D.P., Freeman C.D., Nightingale C.H., et al. Pharmacokinetics of
minocycline and vancomycin in rabbits. Lab Anim Sci. 1993;43:222–225.
101 Nielson V.G., Sidhartha T., Brix A.E., et al. Hextend® (hetastarch solution)
decreases multiple organ injury and xanthine oxidase release after hepatoenteric
ischemia-reperfusion in rabbits. Crit Care Med. 1997;25:1565–1574.
102 Norcross E.W., Sanders M.E., Moore Q., et al. Comparative efficacy of
besifloxacin and other fluoroquinolones in a prophylaxis model of penicillinresistant
Streptococcus pneumoniae rabbit endophthalmitis. J Ocul Pharmacol
Ther. 2010;26:237–243.
103 Ofoefule S.I., Onuoha L.C., Okonta M.J., et al. Effect of activated charcoal on
isoniazid absorption in rabbits. Boll Chim Farm. 2001;140:183–186.
104 Ostergaard C., Sorensen T.K., Knudsen J.D., et al. Evaluation of moxifloxacin, a
new 8-methoxyquinolone, for treatment of meningitis caused by a penicillinresistant
pneumococcus in rabbits. Antimicrob Agents Chemother. 1998;42:1706–
757